Body MR Techniques and MR of the Liver

Body MRI

Volumn , Issue , 2004, Pages 1-62

  Fisher, Adam ^a   Siegelman, Evan S ^b  

^a CROZER CHESTER MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85191842859     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-3740-2.50006-6     Document Type: Chapter

References (491)

1. NG Campeau, CD Johnson, JP Felmlee, et al. (1995) MR imaging of the abdomen with a phased-array multicoil: prospective clinical evaluation. Radiology 195 769-776.
2. IL Cameron, VA Ord and GD Fullerton (1984) Characterization of proton NMR relaxation times in normal and pathological tissues by correlation with other tissue parameters. Magn Reson Imaging 2 97-106.
3. MM Morrin and NM Rofsky (2001) Techniques for liver MR imaging. Magn Reson Imaging Clin N Am 9 675-696. v.
4. MT Keogan, CE Spritzer, EK Paulson, et al. (1996) Liver MR imaging: comparison of respiratory triggered fast spin echo with T2-weighted spin-echo and inversion recovery. Abdom Imaging 21 433-439.
5. D Pauleit, J Textor, R Bachmann, et al. (2001) Improving the detectability of focal liver lesions on T2-weighted MR images: ultrafast breath-hold or respiratory-triggered thin-section MRI? J Magn Reson Imaging 14 128-133.
6. K Ito, DG Mitchell, EK Outwater, J Szklaruk and AG Sadek (1997) Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology 204 729-737.
7. EG McFarland, WW Mayo-Smith, S Saini, PF Hahn, MA Goldberg and MJ Lee (1994) Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 193 43-47.
8. S Kiryu, Y Okada and K Ohtomo (2002) Differentiation between hemangiomas and cysts of the liver with single-shot fast-spin echo image using short and long TE. J Comput Assist Tomogr 26 687-690.
9. T Helmberger and RC Semelka (2001) New contrast agents for imaging the liver. Magn Reson Imaging Clin N Am 9 745-766. vi.
10. AN Oksendal and PA Hals (1993) Biodistribution and toxicity of MR imaging contrast media. J Magn Reson Imaging 3 157-165.
11. RE Hendrick and EM Haacke (1993) Basic physics of MR contrast agents and maximization of image contrast. J Magn Reson Imaging 3 137-148.
12. VS Lee, MT Lavelle, GA Krinsky and NM Rofsky (2001) Volumetric MR imaging of the liver and applications. Magn Reson Imaging Clin N Am 9 697-716. v-vi.
13. JS Yu and NM Rofsky (2003) Dynamic subtraction MR imaging of the liver: advantages and pitfalls. AJR Am J Roentgenol 180 1351-1357.
14. RN Low (2001) MR imaging of the liver using gadolinium chelates. Magn Reson Imaging Clin N Am 9 717-743.
15. HK Hussain, FJ Londy, IR Francis, et al. (2003) Hepatic arterial phase MR imaging with automated bolus-detection three-dimensional fast gradient-recalled-echo sequence: comparison with test-bolus method. Radiology 226 558-566.
16. N Abdou, AM Napoli, MR Hynes, JC Allen Jr. and JH Wible Jr. (2004) Safety assessment of gadoversetamide (OptiMARK) administered by power injector. J Magn Reson Imaging 19 133-140.
17. JP Earls, NM Rofsky, DR DeCorato, GA Krinsky and JC Weinreb (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 202 268-273.
18. L Kopka, R Vosshenrich, J Rodenwaldt and E Grabbe (1998) Differences in injection rates on contrast-enhanced breath-hold three-dimensional MR angiography. AJR Am J Roentgenol 170 345-348.
19. HA Edmondson, B Henderson and B Benton (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294 470-472.
20. LC Tao (1991) Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma: cytomorphology and mechanism of malignant transformation. Cancer 68 341-347.
21. KL Soe, M Soe and C Gluud (1992) Liver pathology associated with the use of anabolic-androgenic steroids. Liver 12 73-79.
22. P Labrune, P Trioche, I Duvaltier, P Chevalier and M Odievre (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24 276-279.
23. T Ichikawa, MP Federle, L Grazioli and M Nalesnik (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214 861-868.
24. EK Paulson, JS McClellan, K Washington, CE Spritzer, WC Meyers and ME Baker (1994) Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 163 113-116.
25. PP Anthony (2002) 1. Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology, and pathology. RNM MacSween, AD Burt, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony (Eds) Pathology of the Liver 4th ed. Churchill Livingstone 711-776.
26. JR Craig, RL Peters and HA Edmondson (1989) Tumors of the liver and intrahepatic bile ducts Washington, D.C.: Armed Forces Institute of Pathology
27. L Grazioli, MP Federle, G Brancatelli, T Ichikawa, L Olivetti and A Blachar (2001) Hepatic adenomas: imaging and pathologic findings. Radiographics 21 877-892. discussion 892-874.
28. L Arrive, JF Flejou, V Vilgrain, et al. (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193 507-512.
29. VJ Casillas, MA Amendola, A Gascue, N Pinnar, JU Levi and JM Perez (2000) Imaging of nontraumatic hemorrhagic hepatic lesions. Radiographics 20 367-378.
30. JH Foster and MM Berman (1994) The malignant transformation of liver cell adenomas. Arch Surg 129 712-717.
31. T Leese, O Farges and H Bismuth (1988) Liver cell adenomas: a 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 208 558-564.
32. M Ito, M Sasaki, CY Wen, et al. (2003) Liver cell adenoma with malignant transformation: a case report. World J Gastroenterol 9 2379-2381.
33. P Kerlin, GL Davis, DB McGill, LH Weiland, MA Adson and PF Sheedy Jr. (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 84 994-1002.
34. BF Flowers, RP McBurney and SR Vera (1990) Ruptured hepatic adenoma: a spectrum of presentation and treatment. Am Surg 56 380-383.
35. P Aseni, CV Sansalone, C Sammartino, et al. (2001) Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol 33 234-236.
36. M Kawakatsu, V Vilgrain, S Erlinger and H Nahum (1997) Disappearance of liver cell adenoma: CT and MR imaging. Abdom Imaging 22 274-276.
37. KY Chung, WW Mayo-Smith, S Saini, A Rahmouni, M Golli and D Mathieu (1995) Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 165 303-308.
38. GT Ault, SM Wren, PW Ralls, TB Reynolds and SC Stain (1996) Selective management of hepatic adenomas. Am Surg 62 825-829.
39. JF Flejou, J Barge, Y Menu, et al. (1985) Liver adenomatosis: an entity distinct from liver adenoma? Gastroenterology 89 1132-1138.
40. A Ribeiro, LJ Burgart, DM Nagorney and GJ Gores (1998) Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 4 388-398.
41. L Grazioli, MP Federle, T Ichikawa, E Balzano, M Nalesnik and J Madariaga (2000) Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 216 395-402.
42. L Chiche, T Dao, E Salame, et al. (2000) Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 231 74-81.
43. PC Buetow, L Pantongrag-Brown, JL Buck, PR Ros and ZD Goodman (1996) Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics 16 369-388.
44. SM Hussain, T Terkivatan, PE Zondervan, et al. (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24 3-17. discussion 18-19.
45. BN Nguyen, JF Flejou, B Terris, J Belghiti and C Degott (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23 1441-1454.
46. D Mathieu, H Kobeiter, P Maison, et al. (2000) Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 118 560-564.
47. I Leconte, BE Van Beers, M Lacrosse, et al. (2000) Focal nodular hyperplasia: natural course observed with CT and MRI. J Comput Assist Tomogr 24 61-66.
48. AE Mahfouz, B Hamm, M Taupitz and KJ Wolf (1993) Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 186 133-138.
49. KJ Mortele, M Praet, H Van Vlierberghe, M Kunnen and PR Ros (2000) CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol 175 687-692.
50. M Dill-Macky, C Frazer and WB de Boer (1999) Magnetic resonance features of focal nodular hyperplasia of the liver. Australas Radiol 43 315-320.
51. DG Mitchell, J Palazzo, HW Hann, MD Rifkin, DL Burk Jr. and R Rubin (1991) Hepatocellular tumors with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15 762-769.
52. KJ Mortele, M Praet, H Van Vlierberghe, B de Hemptinne, K Zou and PR Ros (2002) Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 27 700-707.
53. P Attal, V Vilgrain, G Brancatelli, et al. (2003) Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology 228 465-472.
54. P Soyer, AC Dufresne, E Somveille and A Scherrer (1996) Focal nodular hyperplasia of the liver: assessment of hemodynamic and angioarchitectural patterns with gadolinium chelate-enhanced 3D spoiled gradient-recalled MRI and maximum intensity projection reformatted images. J Comput Assist Tomogr 20 898-904.
55. CK Charny, WR Jarnagin, LH Schwartz, et al. (2001) Management of 155 patients with benign liver tumours. Br J Surg 88 808-813.
56. P Herman, V Pugliese, MA Machado, et al. (2000) Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 24 372-376.
57. A Ba-Ssalamah, W Schima, MT Schmook, et al. (2002) Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 179 1447-1456.
58. JK McLarney, PT Rucker, GN Bender, ZD Goodman, N Kashitani and PR Ros (1999) Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. Radiographics 19 453-471.
59. T Ichikawa, MP Federle, L Grazioli, J Madariaga, M Nalesnik and W Marsh (1999) Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 213 352-361.
60. AD Pinna, S Iwatsuki, RG Lee, et al. (1997) Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26 877-883.
61. T Ichikawa, MP Federle, L Grazioli and W Marsh (2000) Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology 217 145-151.
62. WR Stevens, CD Johnson, DH Stephens and DM Nagorney (1995) Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management. AJR Am J Roentgenol 164 1153-1158.
63. WJ Lee, HK Lim, KM Jang, et al. (2001) Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21(Spec No), S97-S116.
64. JH Lim (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181 819-827.
65. PR Ros, JL Buck, ZD Goodman, AM Ros and WW Olmsted (1988) Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 167 689-693.
66. P Soyer, DA Bluemke, R Reichle, et al. (1995) Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR Am J Roentgenol 165 1427-1431.
67. V Vilgrain, BE Van Beers, JF Flejou, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21 59-65.
68. P Soyer, DA Bluemke, A Sibert and JP Laissy (1995) MR imaging of intrahepatic cholangiocarcinoma. Abdom Imaging 20 126-130.
69. T Nakajima, Y Kondo, M Miyazaki and K Okui (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19 1228-1234.
70. Y Maetani, K Itoh, C Watanabe, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176 1499-1507.
71. T Murakami, H Nakamura, K Tsuda, et al. (1995) Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study. J Magn Reson Imaging 5 165-170.
72. ZM Fan, Y Yamashita, M Harada, et al. (1993) Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 161 313-317.
73. C Powers, PR Ros, C Stoupis, WK Johnson and KH Segel (1994) Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 14 459-482.
74. S Worawattanakul, RC Semelka, TC Noone, BF Calvo, NL Kelekis and JT Woosley (1998) Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 16 993-1003.
75. ON Adjei, S Tamura, H Sugimura, et al. (1995) Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma. Clin Radiol 50 6-10.
76. M Hayashi, O Matsui, K Ueda, et al. (1996) Imaging findings of mucinous type of cholangiocellular carcinoma. J Comput Assist Tomogr 20 386-389.
77. T Gabata, O Matsui, M Kadoya, et al. (1998) Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 23 309-313.
78. TK Kim, BI Choi, JK Han, HJ Jang, SG Cho and MC Han (1997) Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology 204 539-543.
79. Y Zhang, M Uchida, T Abe, H Nishimura, N Hayabuchi and Y Nakashima (1999) Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23 670-677.
80. A Blachar, MP Federle and G Brancatelli (2002) Hepatic capsular retraction: spectrum of benign and malignant etiologies. Abdom Imaging 27 690-699.
81. DM Yang, HS Kim and SW Cho (2002) Pictorial review: various causes of hepatic capsular retraction: CT and MR findings. Br J Radiol 75 994-1002.
82. Y Yamashita, M Takahashi, S Kanazawa, C Charnsangavej and S Wallace (1992) Parenchymal changes of the liver in cholangiocarcinoma: CT evaluation. Gastrointest Radiol 17 161-166.
83. M Jinzaki, A Tanimoto, K Suzuki, et al. (1997) Liver metastases from colon cancer with intra-bile duct tumor growth: radiologic features. J Comput Assist Tomogr 21 656-660.
84. K Shirabe, M Shimada, N Harimoto, et al. (2002) Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 131 S159-164.
85. KG Ishak, GW Willis, SD Cummins and AA Bullock (1977) Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 39 322-338.
86. PC Buetow, JL Buck, L Pantongrag-Brown, et al. (1995) Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology 196 805-810.
87. JM Lauffer, HU Baer, CA Maurer, C Stoupis, A Zimmerman and MW Buchler (1998) Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 34 1845-1851.
88. DA Wheeler and HA Edmondson (1985) Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts: a clinicopathologic study of 17 cases, 4 with malignant change. Cancer 56 1434-1445.
89. K Devaney, ZD Goodman and KG Ishak (1994) Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 18 1078-1091.
90. RS Chamberlain and LH Blumgart (2000) Mucobilia in association with a biliary cystadenocarcinoma of the caudate duct: a rare cause of malignant biliary obstruction. HPB Surg 11 345-351.
91. T Kokubo, Y Itai, K Ohtomo, K Itoh, N Kawauchi and M Minami (1988) Mucin-hypersecreting intrahepatic biliary neoplasms. Radiology 168 609-614.
92. S Matsumoto, H Miyake and H Mori (1997) Case report: biliary cystadenoma with mucin-secretion mimicking a simple hepatic cyst. Clin Radiol 52 316-318.
93. A Kawashima, EK Fishman, RH Hruban, CM Tempany, JE Kuhlman and EA Zerhouni (1991) Biliary cystadenoma with intratumoral bleeding: radiologic-pathologic correlation. J Comput Assist Tomogr 15 1035-1038.
94. P Soyer, DA Bluemke, EK Fishman and R Rymer (1998) Fluid-fluid levels within focal hepatic lesions: imaging appearance and etiology. Abdom Imaging 23 161-165.
95. M Korobkin, DH Stephens, JK Lee, et al. (1989) Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol 153 507-511.
96. Y Singh, AB Winick and SO Tabbara (1997) Multiloculated cystic liver lesions: radiologic-pathologic differential diagnosis. Radiographics 17 219-224.
97. NC Balci and M Sirvanci (2002) MR imaging of infective liver lesions. Magn Reson Imaging Clin N Am 10 121-135.
98. AM Agildere, C Aytekin, M Coskun, F Boyvat and S Boyacioglu (1998) MRI of hydatid disease of the liver: a variety of sequences. J Comput Assist Tomogr 22 718-724.
99. AM Agildere, M Haliloglu and O Akhan (1991) Biliary cystadenoma and cystadenocarcinoma. AJR Am J Roentgenol 156 1113.
100. A Wee, B Nilsson, JY Kang, LK Tan and A Rauff (1993) Biliary cystadenocarcinoma arising in a cystadenoma: report of a case diagnosed by fine needle aspiration cytology. Acta Cytol 37 966-970.
101. GL Woods (1981) Biliary cystadenocarcinoma: Case report of hepatic malignancy originating in benign cystadenoma. Cancer 47 2936-2940.
102. WD Lewis, RL Jenkins, RL Rossi, et al. (1988) Surgical treatment of biliary cystadenoma: a report of 15 cases. Arch Surg 123 563-568.
103. Y Iemoto, Y Kondo and S Fukamachi (1981) Biliary cystadenocarcinoma with peritoneal carcinomatosis. Cancer 48 1664-1667.
104. T Nakajima, I Sugano, O Matsuzaki, et al. (1992) Biliary cystadenocarcinoma of the liver: a clinicopathologic and histochemical evaluation of nine cases. Cancer 69 2426-2432.
105. HK Wolf, JA Garcia and EH Bossen (1992) Oncocytic differentiation in intrahepatic biliary cystadenocarcinoma. Mod Pathol 5 665-668.
106. VJ Desmet (1992) Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation.”. Hepatology 16 1069-1083.
107. VJ Desmet (1998) Ludwig symposium on biliary disorders. 1. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 73 80-89.
108. EB Chung (1970) Multiple bile-duct hamartomas. Cancer 26 287-296.
109. AS Lev-Toaff, AM Bach, RJ Wechsler, PL Hilpert, Z Gatalica and R Rubin (1995) The radiologic and pathologic spectrum of biliary hamartomas. AJR Am J Roentgenol 165 309-313.
110. JC Gallego, I Suarez and R Soler (1995) Multiple bile duct hamartomas: US, CT, and MR findings. A case report. Acta Radiol 36 273-275.
111. MM Maher, P Dervan, B Keogh and JG Murray (1999) Bile duct hamartomas (von Meyenburg complexes): value of MR imaging in diagnosis. Abdom Imaging 24 171-173.
112. C Martinoli, G Cittadini Jr., GA Rollandi and R Conzi (1992) Case report: imaging of bile duct hamartomas. Clin Radiol 45 203-205.
113. YC Cheung, CF Tan, YL Wan, KW Lui and CC Tsai (1997) MRI of multiple biliary hamartomas. Br J Radiol 70 527-529.
114. RC Semelka, SM Hussain, HB Marcos and JT Woosley (1999) Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson Imaging 10 196-201.
115. HW Slone, WF Bennett and JG Bova (1993) MR findings of multiple biliary hamartomas. AJR Am J Roentgenol 161 581-583.
116. SC Wei, GT Huang, CH Chen, et al. (1997) Bile duct hamartomas: a report of two cases. J Clin Gastroenterol 25 608-611.
117. WA Wohlgemuth, J Bottger and K Bohndorf (1998) MRI, CT, US and ERCP in the evaluation of bile duct hamartomas (von Meyenburg complex): a case report. Eur Radiol 8 1623-1626.
118. B Mortele, K Mortele, P Seynaeve, D Vandevelde, M Kunnen and PR Ros (2002) Hepatic bile duct hamartomas (von Meyenburg Complexes): MR and MR cholangiography findings. J Comput Assist Tomogr 26 438-443.
119. GT Everson (1990) Hepatic cysts in autosomal dominant polycystic kidney disease. Mayo Clin Proc 65 1020-1025.
120. Y Itai, R Ebihara, N Eguchi, et al. (1995) Hepatobiliary cysts in patients with autosomal dominant polycystic kidney disease: prevalence and CT findings. AJR Am J Roentgenol 164 339-342.
121. PA Gabow, AM Johnson, WD Kaehny, ML Manco-Johnson, IT Duley and GT Everson (1990) Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11 1033-1037.
122. KJ Mortele and PR Ros (2001) Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21 895-910.
123. E Levine, LT Cook and JJ Grantham (1985) Liver cysts in autosomal- dominant polycystic kidney disease: clinical and computed tomographic study. AJR Am J Roentgenol 145 229-233.
124. KJ van Erpecum, AR Janssens, JL Terpstra and ATRT Tjon (1987) Highly symptomatic adult polycystic disease of the liver: a report of fifteen cases. J Hepatol 5 109-117.
125. A Telenti, VE Torres, JB Gross Jr., RE Van Scoy, ML Brown and RR Hattery (1990) Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 65 933-942.
126. T Kida, Y Nakanuma and T Terada (1992) Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: an autopsy study. Hepatology 16 334-340.
127. T Terada and Y Nakanuma (1990) Pathological observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers. 3. Survey of necroinflammation and cystic dilatation. Hepatology 12 1229-1233.
128. RL Baron, WL Campbell and GD Dodd III (1994) Peribiliary cysts associated with severe liver disease: imaging—pathologic correlation. AJR Am J Roentgenol 162 631-636.
129. D Krause, JP Cercueil, M Dranssart, F Cognet, F Piard and P Hillon (2002) MRI for evaluating congenital bile duct abnormalities. J Comput Assist Tomogr 26 541-552.
130. Y Itai, R Ebihara, E Tohno, et al. (1994) Hepatic peribiliary cysts: multiple tiny cysts within the larger portal tract, hepatic hilum, or both. Radiology 191 107-110.
131. M Dranssart, F Cognet, C Mousson, JP Cercueil, G Rifle and D Krause (2002) MR cholangiography in the evaluation of hepatic and biliary abnormalities in autosomal dominant polycystic kidney disease: study of 93 patients. J Comput Assist Tomogr 26 237-242.
132. V Vilgrain, O Silbermann, JP Benhamou and H Nahum (1993) MR imaging in intracystic hemorrhage of simple hepatic cysts. Abdom Imaging 18 164-167.
133. MA Mosetti, P Leonardou, T Motohara, M Kanematsu, D Armao and RC Semelka (2003) Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques. J Magn Reson Imaging 18 210-215.
134. E vanSonnenberg, JT Wroblicka, HB D'Agostino, et al. (1994) Symptomatic hepatic cysts: percutaneous drainage and sclerosis. Radiology 190 387-392.
135. JV Ferris (2003) Serial ethanol ablation of multiple hepatic cysts as an alternative to liver transplantation. AJR Am J Roentgenol 180 472-474.
136. PA Gaines and MA Sampson (1989) The prevalence and characterization of simple hepatic cysts by ultrasound examination. Br J Radiol 62 335-337.
137. JR Cook, LP Dehner, MH Collins, et al. (2001) Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 25 1364-1371.
138. CM Coffin, PA Humphrey and LP Dehner (1998) Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol 15 85-101.
139. LD Narla, B Newman, SS Spottswood, S Narla and R Kolli (2003) Inflammatory pseudotumor. Radiographics 23 719-729.
140. LP Dehner (2000) The enigmatic inflammatory pseudotumours: the current state of our understanding, or misunderstanding. J Pathol 192 277-279.
141. CM Coffin, LP Dehner and JM Meis-Kindblom (1998) Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol 15 102-110.
142. T Sakai, K Shiraki, N Yamamoto, et al. (2002) Diagnosis of inflammatory pseudotumor of the liver. Int J Mol Med 10 281-285.
143. FH Yan, KR Zhou, YP Jiang and WB Shi (2001) Inflammatory pseudotumor of the liver: 13 cases of MRI findings. World J Gastroenterol 7 422-424.
144. KJ Mortele, W Wiesner, B de Hemptinne, A Elewaut, M Praet and PR Ros (2002) Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. Eur Radiol 12 304-308.
145. G Torzilli, K Inoue, Y Midorikawa, AM Hui, T Takayama and M Makuuchi (2001) Inflammatory pseudotumors of the liver: prevalence and clinical impact in surgical patients. Hepatogastroenterology 48 1118-1123.
146. M Abehsera, V Vilgrain, J Belghiti, JF Flejou and H Nahum (1995) Inflammatory pseudotumor of the liver: radiologic-pathologic correlation. J Comput Assist Tomogr 19 80-83.
147. ME Flisak, DM Budris, MC Olson and EJ Zarling (1994) Inflammatory pseudotumor of the liver: appearance on MRI. Clin Imaging 18 1-3.
148. R Materne, BE Van Beers, JF Gigot, Y Horsmans, M Lacrosse and J Pringot (1998) Inflammatory pseudotumor of the liver: MRI with mangafodipir trisodium. J Comput Assist Tomogr 22 82-84.
149. H Ijuin, N Ono, K Koga, et al. (1997) Inflammatory pseudotumor of the liver—MR imaging findings. Kurume Med J 44 305-313.
150. NL Kelekis, DM Warshauer, RC Semelka, LB Eisenberg and JT Woosley (1995) Inflammatory pseudotumor of the liver: appearance on contrast enhanced helical CT and dynamic MR images. J Magn Reson Imaging 5 551-553.
151. S Levy, A Sauvanet, MD Diebold, C Marcus, N Da Costa and G Thiefin (2001) Spontaneous regression of an inflammatory pseudotumor of the liver presenting as an obstructing malignant biliary tumor. Gastrointest Endosc 53 371-374.
152. Y Nakanuma, K Tsuneyama, S Masuda and T Tomioka (1994) Hepatic inflammatory pseudotumor associated with chronic cholangitis: report of three cases. Hum Pathol 25 86-91.
153. SD Voss, JB Kruskal and RA Kane (1999) Chronic inflammatory pseudotumor arising in the hepatobiliary-pancreatic system: progressive multisystemic organ involvement in four patients. AJR Am J Roentgenol 173 1049-1054.
154. S Venkataraman, RC Semelka, L Braga, IM Danet and JT Woosley (2003) Inflammatory myofibroblastic tumor of the hepatobiliary system: report of MR imaging appearance in four patients. Radiology 227 758-763.
155. P Gollapudi, G Chejfec and EJ Zarling (1992) Spontaneous regression of hepatic pseudotumor. Am J Gastroenterol 87 214-217.
156. R Barreda and PR Ros (1992) Diagnostic imaging of liver abscess. Crit Rev Diagn Imaging 33 29-58.
157. PJ Mergo and PR Ros (1997) MR imaging of inflammatory disease of the liver. Magn Reson Imaging Clin N Am 5 367-376.
158. A Oto, O Akhan and M Ozmen (1999) Focal inflammatory diseases of the liver. Eur J Radiol 32 61-75.
159. PW Ralls (1998) Focal inflammatory disease of the liver. Radiol Clin North Am 36 377-389.
160. FF Chou, SM Sheen-Chen, YS Chen and MC Chen (1997) Single and multiple pyogenic liver abscesses: clinical course, etiology, and results of treatment. World J Surg 21 384-388. discussion 388-389.
161. KT Lee, PC Sheen, JS Chen and CG Ker (1991) Pyogenic liver abscess: multivariate analysis of risk factors. World J Surg 15 372-376. discussion 376-377.
162. NC Balci, RC Semelka, TC Noone, et al. (1999) Pyogenic hepatic abscesses: MRI findings on T1- and T2-weighted and serial gadolinium-enhanced gradient-echo images. J Magn Reson Imaging 9 285-290.
163. RJ Mendez, ML Schiebler, EK Outwater and HY Kressel (1994) Hepatic abscesses: MR imaging findings. Radiology 190 431-436.
164. RB Jeffrey Jr., CS Tolentino, FC Chang and MP Federle (1988) CT of small pyogenic hepatic abscesses: the cluster sign. AJR Am J Roentgenol 151 487-489.
165. T Gabata, M Kadoya, O Matsui, et al. (2001) Dynamic CT of hepatic abscesses: significance of transient segmental enhancement. AJR Am J Roentgenol 176 675-679.
166. JF Schlund, RC Semelka, U Kettritz, LB Eisenberg and JK Lee (1995) Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium-enhanced gradient echo MR images. J Magn Reson Imaging 5 375-377.
167. FJ Miller, DT Ahola, PA Bretzman and DJ Fillmore (1997) Percutaneous management of hepatic abscess: a perspective by interventional radiologists. J Vasc Interv Radiol 8 241-247.
168. E vanSonnenberg, GR Wittich, BW Goodacre, G Casola and HB D'Agostino (2001) Percutaneous abscess drainage: update. World J Surg 25 362-369. discussion 370-372.
169. RC Semelka, NL Kelekis, S Sallah, S Worawattanakul and SM Ascher (1997) Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol 169 1311-1316.
170. GH Talbot, M Provencher and PA Cassileth (1988) Persistent fever after recovery from granulocytopenia in acute leukemia. Arch Intern Med 148 129-135.
171. LS Tashjian, JS Abramson and JE Peacock Jr. (1984) Focal hepatic candidiasis: a distinct clinical variant of candidiasis in immunocompromised patients. Rev Infect Dis 6 689-703.
172. M Thaler, B Pastakia, TH Shawker, T O'Leary and PA Pizzo (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 108 88-100.
173. F Rossetti, DL Brawner, R Bowden, et al. (1995) Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features. Clin Infect Dis 20 801-811.
174. N Grois, G Mostbeck, R Scherrer, et al. (1991) Hepatic and splenic abscesses—a common complication of intensive chemotherapy of acute myeloid leukemia (AML) a prospective study. Ann Hematol 63 33-38.
175. VJ Anttila, AE Lamminen, S Bondestam, et al. (1996) Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia. Eur J Haematol 56 82-87.
176. RC Semelka, JP Shoenut, HM Greenberg and EJ Bow (1992) Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging. J Magn Reson Imaging 2 341-345.
177. NL Kelekis, RC Semelka, HJ Jeon, AS Sallah, TC Shea and JT Woosley (1996) Dark ring sign: finding in patients with fungal liver lesions and transfusional hemosiderosis undergoing treatment with antifungal antibiotics. Magn Reson Imaging 14 615-618.
178. VJ Anttila, P Ruutu, S Bondestam, et al. (1994) Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 18 979-981.
179. EJ Fitzgerald and C Coblentz (1988) Fungal microabscesses in immunosuppressed patients—CT appearances. Can Assoc Radiol J 39 10-12.
180. K Kimura, M Stoopen, MM Reeder and R Moncada (1997) Amebiasis: modern diagnostic imaging with pathological and clinical correlation. Semin Roentgenol 32 250-275.
181. AG Juimo, F Gervez and FF Angwafo (1992) Extraintestinal amebiasis. Radiology 182 181-183.
182. R Haque, CD Huston, M Hughes, E Houpt and WA Petri Jr. (2003) Amebiasis. N Engl J Med 348 1565-1573.
183. G Maltz and CM Knauer (1991) Amebic liver abscess: a 15-year experience. Am J Gastroenterol 86 704-710.
184. R Mondragon-Sanchez, T Cortes-Espinoza, Y Alonzo-Fierro, MI Labra-Villalobos and R Bernal Maldonado (1995) Amebic liver abscess: a 5 year Mexican experience with a multimodality approach. Hepatogastroenterology 42 473-477.
185. G Elizondo, R Weissleder, DD Stark, et al. (1987) Amebic liver abscess: diagnosis and treatment evaluation with MR imaging. Radiology 165 795-800.
186. PW Ralls, DS Henley, PM Colletti, et al. (1987) Amebic liver abscess: MR imaging. Radiology 165 801-804.
187. DR Radin, PW Ralls, PM Colletti and JM Halls (1988) CT of amebic liver abscess. AJR Am J Roentgenol 150 1297-1301.
188. PW Ralls, PF Barnes, MB Johnson, KM De Cock, DR Radin and J Halls (1987) Medical treatment of hepatic amebic abscess: rare need for percutaneous drainage. Radiology 165 805-807.
189. SZ Alvarez (1998) Hepatobiliary tuberculosis. J Gastroenterol Hepatol 13 833-839.
190. MS Gulati, D Sarma and SB Paul (1999) CT appearances in abdominal tuberculosis: a pictorial essay. Clin Imaging 23 51-59.
191. DD Proctor, S Chopra, SC Rubenstein, JA Jokela and L Uhl (1993) Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guérin instillation for bladder carcinoma. Am J Gastroenterol 88 1112-1115.
192. DE Alcantara-Payawal, M Matsumura, Y Shiratori, et al. (1997) Direct detection of Mycobacterium tuberculosis using polymerase chain reaction assay among patients with hepatic granuloma. J Hepatol 27 620-627.
193. Y Murata, I Yamada, Y Sumiya, Y Shichijo and Y Suzuki (1996) Abdominal macronodular tuberculomas: MR findings. J Comput Assist Tomogr 20 643-646.
194. NC Balci, A Tunaci, A Akinci and U Cevikbas (2001) Granulomatous hepatitis: MRI findings. Magn Reson Imaging 19 1107-1111.
195. Y Kawamori, O Matsui, K Kitagawa, M Kadoya, T Takashima and T Yamahana (1992) Macronodular tuberculoma of the liver: CT and MR findings. AJR Am J Roentgenol 158 311-313.
196. CC Wilde and YK Kueh (1991) Case report: Tuberculous hepatic and splenic abscess. Clin Radiol 43 215-216.
197. H Jadvar, RE Mindelzun, EW Olcott and DB Levitt (1997) Still the great mimicker: abdominal tuberculosis. AJR Am J Roentgenol 168 1455-1460.
198. I Tritou, P Prassopoulos, M Daskalogiannaki, N Charoulakis, O Papakonstantinou and N Gourtsoyiannis (2000) Miliary hepatic tuberculosis not associated with splenic or lung involvement: a case report. Acta Radiol 41 479-481.
199. I Pedrosa, A Saiz, J Arrazola, J Ferreiros and CS Pedrosa (2000) Hydatid disease: radiologic and pathologic features and complications. Radiographics 20 795-817.
200. W von Sinner (1997) Advanced medical imaging and treatment of human cystic echinococcosis. Semin Roentgenol 32 276-290.
201. SA Marani, GC Canossi, FA Nicoli, GP Alberti, SG Monni and PM Casolo (1990) Hydatid disease: MR imaging study. Radiology 175 701-706.
202. A Kalovidouris, A Gouliamos, L Vlachos, et al. (1994) MRI of abdominal hydatid disease. Abdom Imaging 19 489-494.
203. Y Kodama, N Fujita, T Shimizu, et al. (2003) Alveolar echinococcosis: MR findings in the liver. Radiology 15 15.
204. I Sayek and D Onat (2001) Diagnosis and treatment of uncomplicated hydatid cyst of the liver. World J Surg 25 21-27.
205. O Akhan and MN Ozmen (1999) Percutaneous treatment of liver hydatid cysts. Eur J Radiol 32 76-85.
206. AD Burt, BC Portmann and RNM MacSween (2002) Liver pathology associated with diseases of other organs or systems. RNM MacSween, AD Burt, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony (Eds) Pathology of the Liver 4th ed. Churchill Livingstone 827-884.
207. F Moreno-Merlo, IR Wanless, K Shimamatsu, M Sherman, P Greig and D Chiasson (1997) The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 26 554-560.
208. DM Warshauer and JK Lee (2004) Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 182 15-28.
209. KG Ishak (1998) Sarcoidosis of the liver and bile ducts. Mayo Clin Proc 73 467-472.
210. DM Warshauer, SA Dumbleton, PL Molina, BC Yankaskas, LA Parker and JT Woosley (1994) Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 192 93-98.
211. DM Warshauer, RC Semelka and SM Ascher (1994) Nodular sarcoidosis of the liver and spleen: appearance on MR images. J Magn Reson Imaging 4 553-557.
212. A Kessler, DG Mitchell, HL Israel and BB Goldberg (1993) Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging 18 159-163.
213. C Charnsangavej, A Cinqualbre and S Wallace (1994) Radiation changes in the liver, spleen, and pancreas: imaging findings. Semin Roentgenol 29 53-63.
214. TS Lawrence, JM Robertson, MS Anscher, RL Jirtle, WD Ensminger and LF Fajardo (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 1237-1248.
215. H Onaya, Y Itai, H Yoshioka, et al. (2000) Changes in the liver parenchyma after proton beam radiotherapy: evaluation with MR imaging. Magn Reson Imaging 18 707-714.
216. EC Unger, JK Lee and PJ Weyman (1987) CT and MR imaging of radiation hepatitis. J Comput Assist Tomogr 11 264-268.
217. DF Yankelevitz, PH Knapp, CI Henschke, L Nisce, Y Yi and P Cahill (1992) MR appearance of radiation hepatitis. Clin Imaging 16 89-92.
218. DP Cutillo, LC Swayne, MG Fasciano and JR Schwartz (1989) Absence of fatty replacement in radiation damaged liver: CT demonstration. J Comput Assist Tomogr 13 259-261.
219. SA Yamasaki, CS Marn, IR Francis, JM Robertson and TS Lawrence (1995) High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis. AJR Am J Roentgenol 165 79-84.
220. YM Lee and MM Kaplan (1995) Primary sclerosing cholangitis. N Engl J Med 332 924-933.
221. BC Portmann and Y Nakanuma (2002) Diseases of the bile ducts. RNM MacSween, AD Burt, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony (Eds) Pathology of the Liver 4th ed. Churchill Livingstone 435-506.
222. G Revelon, A Rashid, S Kawamoto and DA Bluemke (1999) Primary sclerosing cholangitis: MR imaging findings with pathologic correlation. AJR Am J Roentgenol 173 1037-1042.
223. K Ito, DG Mitchell, EK Outwater and R Blasbalg (1999) Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 172 1527-1533.
224. T Gabata, O Matsui, M Kadoya, et al. (1997) Segmental hyperintensity on T1-weighted MRI of the liver: indication of segmental cholestasis. J Magn Reson Imaging 7 855-857.
225. Y Muramatsu, K Takayasu, Y Furukawa, et al. (1997) Hepatic tumor invasion of bile ducts: wedge-shaped sign on MR images. Radiology 205 81-85.
226. GD Dodd III, RL Baron, JH Oliver III and MP Federle (1999) End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 211 357-362.
227. TR Bader, KL Beavers and RC Semelka (2003) MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226 675-685.
228. RJ Zagoria, TJ Roth, EA Levine and PV Kavanagh (2004) Radiofrequency ablation of a symptomatic hepatic cavernous hemangioma. AJR Am J Roentgenol 182 210-212.
229. V Vilgrain, L Boulos, MP Vullierme, A Denys, B Terris and Y Menu (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20 379-397.
230. DM Leifer, WD Middleton, SA Teefey, CO Menias and JR Leahy (2000) Follow-up of patients at low risk for hepatic malignancy with a characteristic hemangioma at US. Radiology 214 167-172.
231. BI Choi, MC Han, JH Park, SH Kim, MH Han and CW Kim (1989) Giant cavernous hemangioma of the liver: CT and MR imaging in 10 cases. AJR Am J Roentgenol 152 1221-1226.
232. M Hotokezaka, M Kojima, K Nakamura, et al. (1996) Traumatic rupture of hepatic hemangioma. J Clin Gastroenterol 23 69-71.
233. HV Nghiem, GA Bogost, JA Ryan, P Lund, PC Freeny and KM Rice (1997) Cavernous hemangiomas of the liver: enlargement over time. AJR Am J Roentgenol 169 137-140.
234. RC Semelka, ED Brown, SM Ascher, et al. (1994) Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192 401-406.
235. GA Tung, JP Vaccaro, JJ Cronan and JM Rogg (1994) Cavernous hemangioma of the liver: pathologic correlation with high-field MR imaging. AJR Am J Roentgenol 162 1113-1117.
236. T Motohara, RC Semelka and L Nagase (2002) MR imaging of benign hepatic tumors. Magn Reson Imaging Clin N Am 10 1-14.
237. MM McNicholas, S Saini, J Echeverri, et al. (1996) T2 relaxation times of hypervascular and non-hypervascular liver lesions: do hypervascular lesions mimic haemangiomas on heavily T2-weighted MR images? Clin Radiol 51 401-405.
238. IM Danet, RC Semelka, L Braga, D Armao and JT Woosley (2003) Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging 21 95-101.
239. IM Danet, RC Semelka, P Leonardou, et al. (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181 809-817.
240. SH Lee, CM Park, IJ Cheong, et al. (2001) Hepatic capsular retraction: unusual finding of cavernous hemangioma. J Comput Assist Tomogr 25 231-233.
241. PS Lim, LN Nazarian, RJ Wechsler and AS Lev-Toaff (2001) Hepatic capsular retraction secondary to involuting cavernous hemangioma. J Comput Assist Tomogr 25 234-235.
242. DM Yang, MH Yoon, HS Kim and JW Chung (2001) Capsular retraction in hepatic giant hemangioma: CT and MR features. Abdom Imaging 26 36-38.
243. M Coumbaras, D Wendum, L Monnier-Cholley, H Dahan, JM Tubiana and L Arrive (2002) CT and MR imaging features of pathologically proven atypical giant hemangiomas of the liver. AJR Am J Roentgenol 179 1457-1463.
244. Y Yamashita, I Ogata, J Urata and M Takahashi (1997) Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 203 121-125.
245. JS Yu, MJ Kim and KW Kim (1998) Intratumoral blood flow in cavernous hemangioma of the liver: radiologic-pathologic correlation. Radiology 208 549-550.
246. EK Outwater, K Ito, E Siegelman, CE Martin, M Bhatia and DG Mitchell (1997) Rapidly enhancing hepatic hemangiomas at MRI: distinction from malignancies with T2-weighted images. J Magn Reson Imaging 7 1033-1039.
247. JF Berger, JP Laissy, O Limot, et al. (1996) Differentiation between multiple liver hemangiomas and liver metastases of gastrinomas: value of enhanced MRI. J Comput Assist Tomogr 20 349-355.
248. DG Mitchell, S Saini, J Weinreb, et al. (1994) Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 193 49-57.
249. WS Whitney, RJ Herfkens, RB Jeffrey, et al. (1993) Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 189 863-870.
250. AE Mahfouz, B Hamm and KJ Wolf (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190 49-52.
251. H Awaya, K Ito, K Honjo, T Fujita, T Matsumoto and N Matsunaga (1998) Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Clin Imaging 22 180-187.
252. MS Peterson, T Murakami and RL Baron (1998) MR imaging patterns of gadolinium retention within liver neoplasms. Abdom Imaging 23 592-599.
253. MG Jeong, JS Yu and KW Kim (2000) Hepatic cavernous hemangioma: temporal peritumoral enhancement during multiphase dynamic MR imaging. Radiology 216 692-697.
254. KW Kim, TK Kim, JK Han, AY Kim, HJ Lee and BI Choi (2001) Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology 219 707-711.
255. CS Li, RC Chen, WT Chen, JM Lii and HY Tu (2003) Temporal peritumoral enhancement of hepatic cavernous hemangioma: findings at multiphase dynamic magnetic resonance imaging. J Comput Assist Tomogr 27 854-859.
256. H Kato, M Kanematsu, M Matsuo, H Kondo and H Hoshi (2001) Atypically enhancing hepatic cavernous hemangiomas: high-spatial-resolution gadolinium-enhanced triphasic dynamic gradient-recalled-echo imaging findings. Eur Radiol 11 2510-2515.
257. K Hanafusa, I Ohashi, Y Himeno, S Suzuki and H Shibuya (1995) Hepatic hemangioma: findings with two-phase CT. Radiology 196 465-469.
258. HC Cheng, SH Tsai, JH Chiang and CY Chang (1995) Hyalinized liver hemangioma mimicking malignant tumor at MR imaging. AJR Am J Roentgenol 165 1016-1017.
259. H Aibe, H Hondo, T Kuroiwa, et al. (2001) Sclerosed hemangioma of the liver. Abdom Imaging 26 496-499.
260. D Mathieu, A Rahmouni, N Vasile, et al. (1994) Sclerosed liver hemangioma mimicking malignant tumor at MR imaging: pathologic correlation. J Magn Reson Imaging 4 506-508.
261. G Brancatelli, MP Federle, A Blachar and L Grazioli (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219 69-74.
262. HJ Jang, TK Kim, HK Lim, et al. (2003) Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR Am J Roentgenol 180 135-141.
263. A Nonomura, Y Mizukami and M Kadoya (1994) Angiomyolipoma of the liver: a collective review. J Gastroenterol 29 95-105.
264. E Carmody, E Yeung and M McLoughlin (1994) Angiomyolipomas of the liver in tuberous sclerosis. Abdom Imaging 19 537-539.
265. WM Tsui, R Colombari, BC Portmann, et al. (1999) Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol 23 34-48.
266. T Ahmadi, Y Itai, M Takahashi, et al. (1998) Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging 23 520-526.
267. LD Hooper, PJ Mergo and PR Ros (1994) Multiple hepatorenal angiomyolipomas: diagnosis with fat suppression, gadolinium-enhanced MRI. Abdom Imaging 19 549-551.
268. H Irie, H Honda, T Kuroiwa, et al. (1999) Hepatic angiomyolipoma: report of changing size and internal composition on follow-up examination in two cases. J Comput Assist Tomogr 23 310-313.
269. HC Yeh, FM Klion, SN Thung and HJ Worman (1996) Angiomyolipoma: ultrasonographic signs of lipomatous hepatic tumors. J Ultrasound Med 15 337-342.
270. P Bergeron, VL Oliva, L Lalonde, et al. (1994) Liver angiomyolipoma: classic and unusual presentations. Abdom Imaging 19 543-545.
271. D Hogemann, P Flemming, H Kreipe and M Galanski (2001) Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol 11 1389-1395.
272. JC Chang, YW Lee and HJ Kim (1994) Preoperative diagnosis of angiomyolipoma of the liver. Abdom Imaging 19 546-548.
273. A Nonomura, Y Mizukami, K Shimizu, M Kadoya and O Matsui (1996) Angiomyolipoma mimicking true lipoma of the liver: report of two cases. Pathol Int 46 221-227.
274. S Worawattanakul, RC Semelka, NL Kelekis and JT Woosley (1996) Hepatic angiomyolipoma with minimal fat content: MR demonstration. Magn Reson Imaging 14 687-689.
275. T Murakami, H Nakamura, S Hori, et al. (1993) Angiomyolipoma of the liver. Ultrasound, CT, MR imaging and angiography. Acta Radiol 34 392-394.
276. PR Ros (1994) Hepatic angiomyolipoma: is fat in the liver friend or foe? Abdom Imaging 19 552-553.
277. JN Bruneton, P Kerboul, J Drouillard, Y Menu, F Normand and N Santini (1987) Hepatic lipomas: ultrasound and computed tomographic findings. Gastrointest Radiol 12 299-303.
278. M Garant and C Reinhold (1996) Residents' corner. Answer to case of the month #36: hepatic lipoma. Can Assoc Radiol J 47 140-142.
279. M Sasaki, K Harada, Y Nakanuma and K Watanabe (1994) Pseudolipoma of Glisson's capsule: report of six cases and review of the literature. J Clin Gastroenterol 19 75-78.
280. PJ Karhunen (1985) Hepatic pseudolipoma. J Clin Pathol 38 877-879.
281. DY Baschinsky, N Weidner, PB Baker and WL Frankel (2001) Primary hepatic anaplastic large-cell lymphoma of T-cell phenotype in acquired immunodeficiency syndrome: a report of an autopsy case and review of the literature. Am J Gastroenterol 96 227-232.
282. L Memeo, I Pecorello, A Ciardi, E Aiello, A De Quarto and U Di Tondo (1999) Primary non-Hodgkin's lymphoma of the liver. Acta Oncol 38 655-658.
283. M Mohler, F Gutzler, B Kallinowski, T Goeser and W Stremmel (1997) Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection. Dig Dis Sci 42 2241-2245.
284. S Sato, T Masuda, H Oikawa, et al. (1999) Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol 94 1669-1673.
285. JY Scoazec, C Degott, N Brousse, et al. (1991) Non-Hodgkin's lymphoma presenting as a primary tumor of the liver: presentation, diagnosis and outcome in eight patients. Hepatology 13 870-875.
286. M Sans, V Andreu, JM Bordas, et al. (1998) Usefulness of laparoscopy with liver biopsy in the assessment of liver involvement at diagnosis of Hodgkin's and non-Hodgkin's lymphomas. Gastrointest Endosc 47 391-395.
287. JL Dargent and C De Wolf-Peeters (1998) Liver involvement by lymphoma: identification of a distinctive pattern of infiltration related to T-cell/histiocyte-rich B-cell lymphoma. Ann Diagn Pathol 2 363-369.
288. R Weissleder, DD Stark, G Elizondo, et al. (1988) MRI of hepatic lymphoma. Magn Reson Imaging 6 675-681.
289. GS Gazelle, MJ Lee, PF Hahn, MA Goldberg, N Rafaat and PR Mueller (1994) US, CT, and MRI of primary and secondary liver lymphoma. J Comput Assist Tomogr 18 412-415.
290. NL Kelekis, RC Semelka, ES Siegelman, et al. (1997) Focal hepatic lymphoma: magnetic resonance demonstration using current techniques including gadolinium enhancement. Magn Reson Imaging 15 625-636.
291. MA Nalesnik (1996) Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg 8 139-148.
292. SG Hübscher and BC Portmann (2002) Transplantation Pathology. RNM MacSween, AD Burt, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony (Eds) Pathology of the Liver 4th ed. Churchill Livingstone 885-941.
293. PJ Strouse, JF Platt, IR Francis and RL Bree (1996) Tumorous intrahepatic lymphoproliferative disorder in transplanted livers. AJR Am J Roentgenol 167 1159-1162.
294. NL Harris, ES Jaffe, J Diebold, et al. (2000) The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues. Histopathology 36 69-86.
295. PJ Pickhardt and MJ Siegel (1998) Abdominal manifestations of posttransplantation lymphoproliferative disorder. AJR Am J Roentgenol 171 1007-1013.
296. CS Pena, FS Chew and SB Keel (1998) Posttransplantation lymphoproliferative disorder of the liver. AJR Am J Roentgenol 171 192.
297. S Kaushik, AS Fulcher, WJ Frable and DA May (2001) Posttransplantation lymphoproliferative disorder: osseous and hepatic involvement. AJR Am J Roentgenol 177 1057-1059.
298. AR Moody, SR Wilson and PD Greig (1992) Non-Hodgkin lymphoma in the porta hepatis after orthotopic liver transplantation: sonographic findings. Radiology 182 867-870.
299. G Lin, A Lunderquist, I Hagerstrand and E Boijsen (1984) Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 96 517-526.
300. G Lin, I Hagerstrand and A Lunderquist (1984) Portal blood supply of liver metastases. AJR Am J Roentgenol 143 53-55.
301. GT Sica, H Ji and PR Ros (2002) Computed tomography and magnetic resonance imaging of hepatic metastases. Clin Liver Dis 6 165-179.
302. G Haugeberg, T Strohmeyer, W Lierse and W Bocker (1988) The vascularization of liver metastases. Histological investigation of gelatine-injected liver specimens with special regard to the vascularization of micrometastases. J Cancer Res Clin Oncol 114 415-419.
303. Z Kan, K Ivancev, A Lunderquist, et al. (1993) In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 187 621-626.
304. JJ Killion and IJ Fidler (1989) The biology of tumor metastasis. Semin Oncol 16 106-115.
305. ME Baker and R Pelley (1995) Hepatic metastases: basic principles and implications for radiologists. Radiology 197 329-337.
306. E Wisse, RB De Zanger, K Charels, P Van Der Smissen and RS McCuskey (1985) The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 5 683-692.
307. J Scheele, R Stang, A Altendorf-Hofmann and M Paul (1995) Resection of colorectal liver metastases. World J Surg 19 59-71.
308. Y Fong, AM Cohen, JG Fortner, et al. (1997) Liver resection for colorectal metastases. J Clin Oncol 15 938-946.
309. SR Bramhall, U Gur, C Coldham, et al. (2003) Liver resection for colorectal metastases. Ann R Coll Surg Engl 85 334-339.
310. PJ Karhunen (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39 183-188.
311. LH Schwartz, EJ Gandras, SM Colangelo, MC Ercolani and DM Panicek (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210 71-74.
312. TC Noone, RC Semelka, NC Balci and ML Graham (1999) Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases. J Magn Reson Imaging 10 165-169.
313. RC Semelka, DR Martin, C Balci and T Lance (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13 397-401.
314. RC Semelka, S Worawattanakul, NL Kelekis, et al. (1997) Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imaging 7 1040-1047.
315. K Imam and DA Bluemke (2000) MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin N Am 8 741-756.
316. KH Lewis and JL Chezmar (1997) Hepatic metastases. Magn Reson Imaging Clin N Am 5 319-330.
317. JL Turkenburg, ME Pijl, EL van Persijn van Meerten, J Hermans and JL Bloem (1999) MRI of liver metastases: limitation of spleen-liver model in optimizing pulse sequences. J Magn Reson Imaging 9 369-372.
318. MJ Lee, PF Hahn, S Saini and PR Mueller (1992) Differential diagnosis of hyperintense liver lesions on T1-weighted MR images. AJR Am J Roentgenol 159 1017-1020.
319. NL Kelekis, RC Semelka and JT Woosley (1996) Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging 6 291-294.
320. GT Sica, H Ji and PR Ros (2000) CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 174 691-698.
321. A Premkumar, L Sanders, F Marincola, I Feuerstein, R Concepcion and D Schwartzentruber (1992) Visceral metastases from melanoma: findings on MR imaging. AJR Am J Roentgenol 158 293-298.
322. ML Esensten, SL Shaw, HY Pak and HL Gildenhorn (1983) CT demonstration of multiple intraperitoneal teratomatous implants. J Comput Assist Tomogr 7 1117-1118.
323. MS Pedro, RC Semelka and L Braga (2002) MR imaging of hepatic metastases. Magn Reson Imaging Clin N Am 10 15-29.
324. RC Semelka, AS Bagley, ED Brown and MA Kroeker (1994) Malignant lesions of the liver identified on T1- but not T2-weighted MR images at 1.5 T. J Magn Reson Imaging 4 315-318.
325. M Kanematsu, H Hoshi, K Kunieda, Y Nandate, M Kato and R Yokoyama (1998) Metastases in fatty liver: appearance on conventional spin-echo, fast-spin-echo, and echo-planar T2-weighted MR images. Radiat Med 16 175-177.
326. EK Outwater, DG Mitchell and S Vinitski (1994) Abdominal MR imaging: evaluation of a fast spin-echo sequence. Radiology 190 425-429.
327. A Giovagnoni, F Terilli, P Ercolani, E Paci and A Piga (1994) MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion. AJR Am J Roentgenol 163 1093-1097.
328. MJ Lee, S Saini, CC Compton and RA Malt (1991) MR demonstration of edema adjacent to a liver metastasis: pathologic correlation. AJR Am J Roentgenol 157 499-501.
329. E Outwater, JE Tomaszewski, JM Daly and HY Kressel (1991) Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 180 327-332.
330. Y Itai and T Irie (2001) Metastatic liver tumor: circumferential versus wedge-shaped perilesional enhancement and quantitative image and pathologic correlation. Radiology 219 298-300.
331. AB Nascimento, DG Mitchell, R Rubin and E Weaver (2001) Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases. Radiology 221 117-121.
332. SA Schreiner, B Gorman and DH Stephens (1998) Chemotherapy-related hepatotoxicity causing imaging findings resembling cirrhosis. Mayo Clin Proc 73 780-783.
333. A Shirkhoda and S Baird (1994) Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings. Abdom Imaging 19 39-42.
334. ST Young, EK Paulson, K Washington, DJ Gulliver, JJ Vredenburgh and ME Baker (1994) CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 163 1385-1388.
335. Y Falck-Ytter, ZM Younossi, G Marchesini and AJ McCullough (2001) Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 21 17-26.
336. EM Brunt (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21 3-16.
337. M Nishino, K Hayakawa, Y Nakamura, T Morimoto and S Mukaihara (2003) Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 180 129-134.
338. JM Clark and AM Diehl (2003) Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. Jama 289 3000-3004.
339. J Martin, J Puig, J Falco, et al. (1998) Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging. Radiology 207 325-330.
340. J Martin, M Sentis, A Zidan, et al. (1995) Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. Radiology 195 125-130.
341. D Mathieu, M Paret, AE Mahfouz, et al. (1997) Hyperintense benign liver lesions on spin-echo T1-weighted MR images: pathologic correlations. Abdom Imaging 22 410-417.
342. ES Siegelman and MA Rosen (2001) Imaging of hepatic steatosis. Semin Liver Dis 21 71-80.
343. Y Tsushima and PB Dean (1995) Characterization of adrenal masses with chemical shift MR imaging: how to select echo times. Radiology 195 285-286.
344. S Venkataraman, L Braga and RC Semelka (2002) Imaging the fatty liver. Magn Reson Imaging Clin N Am 10 93-103.
345. TJ Kroncke, M Taupitz, D Kivelitz, et al. (2000) Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol 10 1095-1100.
346. J Kemper, G Jung, LW Poll, C Jonkmanns, R Luthen and U Moedder (2002) CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging 27 708-710.
347. O Matsui, M Kadoya, S Takahashi, et al. (1995) Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. AJR Am J Roentgenol 164 1137-1140.
348. I Ohashi, H Ina, N Gomi, et al. (1995) Hepatic pseudolesion in the left lobe around the falciform ligament at helical CT. Radiology 196 245-249.
349. O Matsui, T Takashima, M Kadoya, et al. (1987) Staining in the liver surrounding gallbladder fossa on hepatic arteriography caused by increased cystic venous drainage. Gastrointest Radiol 12 307-312.
350. ES Siegelman (1997) MR imaging of diffuse liver disease. Hepatic fat and iron. Magn Reson Imaging Clin N Am 5 347-365.
351. T Arita, N Matsunaga, Y Honma, E Nishikawa and S Nagaoka (1996) Focally spared area of fatty liver caused by arterioportal shunt. J Comput Assist Tomogr 20 360-362.
352. M Grossholz, F Terrier, L Rubbia, et al. (1998) Focal sparing in the fatty liver as a sign of an adjacent space-occupying lesion. AJR Am J Roentgenol 171 1391-1395.
353. Y Itai (2000) Peritumoral sparing of fatty liver: another important instance of focal sparing caused by a hepatic tumor. AJR Am J Roentgenol 174 868-870.
354. JJ Chung, MJ Kim, JH Kim, JT Lee and HS Yoo (2003) Fat Sparing of Surrounding Liver From Metastasis in Patients with Fatty Liver: MR Imaging with Histopathologic Correlation. AJR Am J Roentgenol 180 1347-1350.
355. J Sohn, E Siegelman and A Osiason (2001) Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 176 471-474.
356. K Khalili, FP Lan, AE Hanbidge, D Muradali, DG Oreopoulos and IR Wanless (2003) Hepatic Subcapsular Steatosis in Response to Intraperitoneal Insulin Delivery: CT Findings and Prevalence. AJR Am J Roentgenol 180 1601-1604.
357. JF Markmann, M Rosen, ES Siegelman, et al. (2003) Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes 52 1591-1594.
358. ES Siegelman, DG Mitchell, R Rubin, et al. (1991) Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. Radiology 179 361-366.
359. ES Siegelman, DG Mitchell and RC Semelka (1996) Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 199 13-22.
360. S Pomerantz and ES Siegelman (2002) MR imaging of iron depositional disease. Magn Reson Imaging Clin N Am 10 105-120.
361. C Chapoutot, M Esslimani, Z Joomaye, et al. (2000) Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 46 711-714.
362. NC Andrews (1999) Disorders of iron metabolism. N Engl J Med 341 1986-1995.
363. Y Deugnier and B Turlin (2001) Iron and hepatocellular carcinoma. J Gastroenterol Hepatol 16 491-494.
364. JN Feder, A Gnirke, W Thomas, et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 399-408.
365. PR Flanagan, D Lam, D Banerjee and LS Valberg (1989) Ferritin release by mononuclear cells in hereditary hemochromatosis. J Lab Clin Med 113 145-150.
366. G Fillet, Y Beguin and L Baldelli (1989) Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood 74 844-851.
367. C Niederau, A Erhardt, D Haussinger and G Strohmeyer (1999) Haemochromatosis and the liver. J Hepatol 30 6-11.
368. R Voelker (2003) Hemochromatosis patients are untapped source of blood as war, shortages loom. Jama 289 1364-1366.
369. JM Alustiza, J Artetxe, A Castiella, et al. (2004) MR Quantification of Hepatic Iron Concentration. Radiology 230 479-484.
370. ES Siegelman, DG Mitchell and RC Semelka (1996) Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 199 13-22.
371. LJ Anderson, S Holden, B Davis, et al. (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 2171-2179.
372. S Wahid and S Ball (2001) The pituitary gland and hereditary haemochromatosis. Lancet 357 115.
373. D Guyader, Y Gandon, T Sapey, et al. (1999) Magnetic resonance iron-free nodules in genetic hemochromatosis. Am J Gastroenterol 94 1083-1086.
374. DY Yoon, BI Choi, JK Han, MC Han, MO Park and SJ Suh (1994) MR findings of secondary hemochromatosis: transfusional vs erythropoietic. J Comput Assist Tomogr 18 416-419.
375. B Turlin and Y Deugnier (2002) Iron overload disorders. Clin Liver Dis 6 481-496. viii.
376. M Westwood, LJ Anderson, DN Firmin, et al. (2003) A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 18 33-39.
377. ZJ Wang, JC Haselgrove, MB Martin, et al. (2002) Evaluation of iron overload by single voxel MRS measurement of liver T2. J Magn Reson Imaging 15 395-400.
378. ES Siegelman, DG Mitchell, E Outwater, SJ Munoz and R Rubin (1993) Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients. Radiology 188 637-641.
379. IR Wanless (2002) Vascular disorders. RNM MacSween, AD Burt, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony (Eds) Pathology of the Liver 4th ed. Churchill Livingstone 539-573.
380. RL Titton and FV Coakley (2002) Case 51: paroxysmal nocturna hemoglobinuria with thrombotic Budd-Chiari syndrome and renal cortical hemosiderin. Radiology 225 67-70.
381. R Kane and S Eustace (1995) Diagnosis of Budd-Chiari syndrome: comparison between sonography and MR angiography. Radiology 195 117-121.
382. TC Noone, RC Semelka, ES Siegelman, et al. (2000) Budd-Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging 11 44-50.
383. A Erden, I Erden, S Karayalcin and C Yurdaydin (2002) Budd-Chiari syndrome: evaluation with multiphase contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol 179 1287-1292.
384. JH Park, JK Han, BI Choi and MC Han (1991) Membranous obstruction of the inferior vena cava with Budd-Chiari syndrome: MR imaging findings. J Vasc Interv Radiol 2 463-469.
385. K Okuda (2002) Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 22 15-26.
386. TS Desser, DY Sze and RB Jeffrey (2003) Imaging and intervention in the hepatic veins. AJR Am J Roentgenol 180 1583-1591.
387. D Valla and JP Benhamou (1996) Obstruction of the hepatic veins or suprahepatic inferior vena cava. Dig Dis 14 99-118.
388. PN Kim, DG Mitchell and EK Outwater (1999) Budd-Chiari syndrome: hepatic venous obstruction by an elevated diaphragm. Abdom Imaging 24 267-271.
389. K Takayasu, Y Muramatsu, N Moriyama, et al. (1994) Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases. Am J Gastroenterol 89 249-253.
390. H Okuda, H Yamagata, H Obata, et al. (1995) Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 22 1-9.
391. V Vilgrain, M Lewin, C Vons, et al. (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 210 443-450.
392. G Brancatelli, MP Federle, L Grazioli, R Golfieri and R Lencioni (2002) Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics 22 847-862.
393. G Brancatelli, MP Federle, L Grazioli, R Golfieri and R Lencioni (2002) Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 178 877-883.
394. M Arvanitaki and M Adler (2001) Nodular regenerative hyperplasia of the liver: a review of 14 cases. Hepatogastroenterology 48 1425-1429.
395. F Kondo (2001) Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 16 1319-1328.
396. Y Maetani, K Itoh, H Egawa, et al. (2002) Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar. AJR Am J Roentgenol 178 869-875.
397. R Soler, E Rodriguez, F Pombo, J Gonzalez, S Pombo and C Prada (2000) Benign regenerative nodules with copper accumulation in a case of chronic Budd-Chiari syndrome: CT and MR findings. Abdom Imaging 25 486-489.
398. LD DeLeve, HM Shulman and GB McDonald (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22 27-42.
399. P Richardson and E Guinan (2001) Hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Acta Haematol 106 57-68.
400. MA van den Bosch and L van Hoe (2000) MR imaging findings in two patients with hepatic veno-occlusive disease following bone marrow transplantation. Eur Radiol 10 1290-1293.
401. KJ Mortele, H Van Vlierberghe, W Wiesner and PR Ros (2002) Hepatic veno-occlusive disease: MRI findings. Abdom Imaging 27 523-526.
402. RM Gore, DG Mathieu, EM White, GG Ghahremani, JS Panella and D Rochester (1994) Passive hepatic congestion: cross-sectional imaging features. AJR Am J Roentgenol 162 71-75.
403. CE Spritzer (1997) Vascular diseases and MR angiography of the liver. Magn Reson Imaging Clin N Am 5 377-396.
404. HR Parvey, B Raval and CM Sandler (1994) Portal vein thrombosis: imaging findings. AJR Am J Roentgenol 162 77-81.
405. S Kawamoto, PA Soyer, EK Fishman and DA Bluemke (1998) Nonneoplastic liver disease: evaluation with CT and MR imaging. Radiographics 18 827-848.
406. M Matsuo, M Kanematsu, Y Nishigaki, et al. (2002) Pseudothrombosis with T2-weighted fast spin-echo MR images caused by static portal venous flow in severe cirrhosis. J Magn Reson Imaging 15 199-202.
407. AM De Gaetano, M Lafortune, H Patriquin, A De Franco, B Aubin and K Paradis (1995) Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR Am J Roentgenol 165 1151-1155.
408. B Song, P Min, M Oudkerk, et al. (2000) Cavernous transformation of the portal vein secondary to tumor thrombosis of hepatocellular carcinoma: spiral CT visualization of the collateral vessels. Abdom Imaging 25 385-393.
409. PV Pandharipande, VS Lee, GR Morgan, et al. (2001) Vascular and extravascular complications of liver transplantation: comprehensive evaluation with three-dimensional contrast-enhanced volumetric MR imaging and MR cholangiopancreatography. AJR Am J Roentgenol 177 1101-1107.
410. JF Glockner, AR Forauer, H Solomon, CR Varma and WH Perman (2000) Three-dimensional gadolinium-enhanced MR angiography of vascular complications after liver transplantation. AJR Am J Roentgenol 174 1447-1453.
411. K Ito, ES Siegelman, AH Stolpen and DG Mitchell (2000) MR imaging of complications after liver transplantation. AJR Am J Roentgenol 175 1145-1149.
412. DB Stafford-Johnson, BH Hamilton, Q Dong, et al. (1998) Vascular complications of liver transplantation: evaluation with gadolinium-enhanced MR angiography. Radiology 207 153-160.
413. N Erbay, V Raptopoulos, EA Pomfret, IR Kamel and JB Kruskal (2003) Living donor liver transplantation in adults: vascular variants important in surgical planning for donors and recipients. AJR Am J Roentgenol 181 109-114.
414. P Lang, P Schnarkowski, S Grampp, et al. (1995) Liver transplantation: significance of the periportal collar on MRI. J Comput Assist Tomogr 19 580-585.
415. DW Hanto (2003) A 50-year-old man with hepatitis C and cirrhosis needing liver transplantation. Jama 290 3238-3246.
416. HK Hussain and HV Nghiem (2002) Imaging of hepatic transplantation. Clin Liver Dis 6 247-270.
417. S Bhattacharjya, BK Gunson, DF Mirza, et al. (2001) Delayed hepatic artery thrombosis in adult orthotopic liver transplantation—a 12-year experience. Transplantation 71 1592-1596.
418. BS Kim, TK Kim, DJ Jung, et al. (2003) Vascular complications after living related liver transplantation: evaluation with gadolinium-enhanced three-dimensional MR angiography. AJR Am J Roentgenol 181 467-474.
419. AB Zajko, PJ Tobben, CO Esquivel and TE Starzl (1989) Pseudoaneurysms following orthotopic liver transplantation: clinical and radiologic manifestations. Transplant Proc 21 2457-2459.
420. U Settmacher, NC Nussler, M Glanemann, et al. (2000) Venous complications after orthotopic liver transplantation. Clin Transplant 14 235-241.
421. JV Ferris, RL Baron, JW Marsh Jr., JH Oliver III, BI Carr and GD Dodd III (1996) Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology 198 233-238.
422. JM Crawford (2002) Liver Cirrhosis. RNM MacSween, AD Burt, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony (Eds) Pathology of the Liver 4th ed. Churchill Livingstone 575-619.
423. SL Flamm (2003) Chronic hepatitis C virus infection. Jama 289 2413-2417.
424. WP International (1995) Terminology of Nodular Hepatocellular Lesions. Hepatology 22 983-993.
425. ND Theise, YN Park and M Kojiro (2002) Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 6 497-512.
426. JP Earls, ND Theise, JC Weinreb, et al. (1996) Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201 207-214.
427. GA Krinsky and VS Lee (2000) MR imaging of cirrhotic nodules. Abdom Imaging 25 471-482.
428. GD Dodd III, RL Baron, JH Oliver III and MP Federle (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis: part I, gross morphology and diffuse abnormalities. AJR Am J Roentgenol 173 1031-1036.
429. K Ito, DG Mitchell, HW Hann, et al. (1998) Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation. Radiology 207 729-735.
430. K Ito, DG Mitchell and T Gabata (2000) Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging 11 136-140.
431. K Ito, DG Mitchell, T Gabata and SM Hussain (1999) Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 211 723-726.
432. K Ito, DG Mitchell, HW Hann, et al. (1999) Viral-induced cirrhosis: grading of severity using MR imaging. AJR Am J Roentgenol 173 591-596.
433. SJ Rosenthal, LA Harrison, KG Baxter, LH Wetzel, GG Cox and S Batnitzky (1995) Doppler US of helical flow in the portal vein. Radiographics 15 1103-1111.
434. M Lafortune, L Matricardi, A Denys, M Favret, R Dery and G Pomier-Layrargues (1998) Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US. Radiology 206 157-160.
435. H Okazaki, K Ito, T Fujita, S Koike, K Takano and N Matsunaga (2000) Discrimination of alcoholic from virus-induced cirrhosis on MR imaging. AJR Am J Roentgenol 175 1677-1681.
436. K Ito, DG Mitchell and ES Siegelman (2002) Cirrhosis: MR imaging features. Magn Reson Imaging Clin N Am 10 75-92.
437. K Ohtomo, RL Baron, GD Dodd III, MP Federle, Y Ohtomo and SR Confer (1993) Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 189 871-874.
438. RL Baron and MS Peterson (2001) From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics 21(Spec No), S117-132.
439. JS Wenzel, A Donohoe, KL Ford III, K Glastad, D Watkins and E Molmenti (2001) Primary biliary cirrhosis: MR imaging findings and description of MR imaging periportal halo sign. AJR Am J Roentgenol 176 885-889.
440. MJ Kim, DG Mitchell, K Ito, HW Hann, YN Park and PN Kim (2001) Hepatic iron deposition on MR imaging in patients with chronic liver disease: correlation with serial serum ferritin concentration. Abdom Imaging 26 149-156.
441. GA Krinsky and G Israel (2003) Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. AJR Am J Roentgenol 180 1023-1027.
442. T Kim, RL Baron and MA Nalesnik (2000) Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR Am J Roentgenol 175 1121-1125.
443. KM Vitellas, MT Tzalonikou, WF Bennett, KK Vaswani and JG Bova (2001) Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging. Abdom Imaging 26 601-615.
444. GA Krinsky, VS Lee, ND Theise, et al. (2001) Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219 445-454.
445. GD Dodd III, RL Baron, JH Oliver III and MP Federle (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis. 2. Focal abnormalities. AJR Am J Roentgenol 173 1185-1192.
446. YN Park, CP Yang, GJ Fernandez, O Cubukcu, SN Thung and ND Theise (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22 656-662.
447. GA Krinsky, ND Theise, NM Rofsky, H Mizrachi, LW Tepperman and JC Weinreb (1998) Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging—a case report. Radiology 209 461-464.
448. GA Krinsky, VS Lee, MT Nguyen, et al. (2001) Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 218 47-53.
449. GA Krinsky, VS Lee, MT Nguyen, et al. (2000) Siderotic nodules at MR imaging: regenerative or dysplastic? J Comput Assist Tomogr 24 773-776.
450. DG Mitchell, R Rubin, ES Siegelman, DL Burk Jr. and MD Rifkin (1991) Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 178 101-103.
451. AG Sadek, DG Mitchell, ES Siegelman, EK Outwater, T Matteucci and HW Hann (1995) Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 195 753-756.
452. GA Krinsky, VS Lee and ND Theise (2000) Focal lesions in the cirrhotic liver: high resolution ex vivo MRI with pathologic correlation. J Comput Assist Tomogr 24 189-196.
453. AD Burt and CP Day (2002) Pathophysiology of the liver. RNM MacSween, AD Burt, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony (Eds) Pathology of the Liver 4th ed. Churchill Livingstone 67-105.
454. M Kim, DG Mitchell and K Ito (2000) Portosystemic collaterals of the upper abdomen: review of anatomy and demonstration on MR imaging. Abdom Imaging 25 462-470.
455. M Matsuo, M Kanematsu, T Kim, et al. (2003) Esophageal Varices: Diagnosis with Gadolinium-Enhanced MR Imaging of the Liver for Patients with Chronic Liver Damage. AJR Am J Roentgenol 180 461-466.
456. T Sagoh, K Itoh, K Togashi, et al. (1989) Gamna-Gandy bodies of the spleen: evaluation with MR imaging. Radiology 172 685-687.
457. M Minami, Y Itai, K Ohtomo, et al. (1989) Siderotic nodules in the spleen: MR imaging of portal hypertension. Radiology 172 681-684.
458. JA Guingrich and JE Kuhlman (1999) Colonic wall thickening in patients with cirrhosis: CT findings and clinical implications. AJR Am J Roentgenol 172 919-924.
459. OI Karahan, GD Dodd III, KN Chintapalli, H Rhim and S Chopra (2000) Gastrointestinal wall thickening in patients with cirrhosis: frequency and patterns at contrast-enhanced CT. Radiology 215 103-107.
460. S Chopra, GD Dodd III, KN Chintapalli, CC Esola and AA Ghiatas (1999) Mesenteric, omental, and retroperitoneal edema in cirrhosis: frequency and spectrum of CT findings. Radiology 211 737-742.
461. J Szklaruk, PM Silverman and C Charnsangavej (2003) Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol 180 441-454.
462. TJ Liang and M Ghany (2002) Hepatitis B e Antigen—the dangerous endgame of hepatitis B. N Engl J Med 347 208-210.
463. KH Lee, ME O'Malley, JR Kachura, M Haider and A Hanbidge (2003) Pictorial essay—hepatocellular carcinoma: imaging and imaging-guided intervention. AJR Am J Roentgenol 180 1015-1022.
464. L Benvegnu, G Fattovich, F Noventa, et al. (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Cancer 74 2442-2448.
465. NL Kelekis, RC Semelka, S Worawattanakul, et al. (1998) Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 170 1005-1013.
466. M Ebara, H Fukuda, Y Kojima, et al. (1999) Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 210 81-88.
467. Y Koushima, M Ebara, H Fukuda, et al. (2002) Small hepatocellular carcinoma: assessment with T1-weighted spin-echo magnetic resonance imaging with and without fat suppression. Eur J Radiol 41 34-41.
468. J Yoshikawa, O Matsui, T Takashima, et al. (1988) Fatty metamorphosis in hepatocellular carcinoma: radiologic features in 10 cases. AJR Am J Roentgenol 151 717-720.
469. E Sugihara, T Murakami, T Kim, et al. (2003) Detection of hypervascular hepatocellular carcinoma with dynamic magnetic resonance imaging with simultaneously obtained in-phase and opposed-phase echo images. J Comput Assist Tomogr 27 110-116.
470. T Fujita, K Ito, K Honjo, H Okazaki, T Matsumoto and N Matsunaga (1999) Detection of hepatocellular carcinoma: comparison of T2-weighted breath-hold fast spin-echo sequences and high-resolution dynamic MR imaging with a phased-array body coil. J Magn Reson Imaging 9 274-279.
471. HK Hussain, I Syed, HV Nghiem, et al. (2004) T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology
472. G Brancatelli, MP Federle, L Grazioli and BI Carr (2002) Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents. Radiology 222 89-94.
473. CB Winston, LH Schwartz, Y Fong, LH Blumgart and DM Panicek (1999) Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 210 75-79.
474. SM Hussain, RC Semelka and DG Mitchell (2002) MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 10 31-52.
475. SC Efremidis and P Hytiroglou (2002) The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 12 753-764.
476. Y Yamashita, ZM Fan, H Yamamoto, et al. (1994) Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 4 83-90.
477. RC Carlos, HM Kim, HK Hussain, IR Francis, HV Nghiem and AM Fendrick (2003) Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis. AJR Am J Roentgenol 180 893-900.
478. T Fujita, K Honjo, K Ito, T Matsumoto, N Matsunaga and B Hamm (1997) High-resolution dynamic MR imaging of hepatocellular carcinoma with a phased-array body coil. Radiographics 17 315-331. discussion 332-315.
479. M Kajiwara (1997) MR imaging of small hepatocellular carcinoma (≤20 mm): correlation with vascularity and histological features. Kurume Med J 44 327-338.
480. L Grazioli, L Olivetti, C Fugazzola, et al. (1999) The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 9 62-67.
481. T Imaeda, M Kanematsu, R Mochizuki, H Goto, S Saji and K Shimokawa (1994) Extracapsular invasion of small hepatocellular carcinoma: MR and CT findings. J Comput Assist Tomogr 18 755-760.
482. TJ Tsai, GY Chau, WY Lui, et al. (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127 603-608.
483. S Katyal, JH Oliver III, MS Peterson, JV Ferris, BS Carr and RL Baron (2000) Extrahepatic metastases of hepatocellular carcinoma. Radiology 216 698-703.
484. GD Dodd III, RL Baron, JH Oliver III, MP Federle and PB Baumgartel (1997) Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients. Radiology 203 127-130.
485. WB Eubank, KL Wherry, JH Maki, H Sahin, CP Funkhouser and UP Schmiedl (2002) Preoperative evaluation of patients awaiting liver transplantation: Comparison of multiphasic contrast-enhanced 3D magnetic resonance to helical computed tomography examinations. J Magn Reson Imaging 16 565-575.
486. MG Jeong, JS Yu, KW Kim, BJ Jo and JK Kim (1999) Early homogeneously enhancing hemangioma versus hepatocellular carcinoma: differentiation using quantitative analysis of multiphasic dynamic magnetic resonance imaging. Yonsei Med J 40 248-255.
487. A Shimizu, K Ito, S Koike, T Fujita, K Shimizu and N Matsunaga (2003) Cirrhosis or chronic hepatitis: evaluation of small (≤2 cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 226 550-555.
488. B Bhartia, J Ward, JA Guthrie and PJ Robinson (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 180 577-584.
489. TJ Vogl, R Hammerstingl, W Schwarz, et al. (1996) Superparamagnetic iron oxide–enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198 881-887.
490. H Kato, M Kanematsu, H Kondo, et al. (2004) Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging 19 76-81.
491. K Yoshimitsu, DG Varma and EF Jackson (1995) Unsuppressed fat in the right anterior diaphragmatic region on fat-suppressed T2-weighted fast spin-echo MR images. J Magn Reson Imaging 5 145-149.